Address

Pappas Ventures
Research Triangle Park
PO Box 110287
NC 27709
United States

Open map


Recent investment activity

Tags
KANDO id: 3260

Corporate information

Also known as
Pappas Capital
Registration country

Funding rounds

Top investment portfolio themes

Actual initial investment stage
N/A (1)

Investment activity status
Active investor

Selected investments

Displaying 1 - 25 of 63
Profile Country Date Sort ascending Funding
Lumena Pharmaceuticals Inc Series A
IlluminOss Medical Inc A privately held medical device company dedicated to the development of minimally invasive orthopedic systems. Series C
CardioDx Inc Series F Initial investment
CoLucid Pharmaceuticals Biopharmaceutical company developing therapeutics to treat neurological dysfunctions. N/A
CardioDx Inc Series E Initial investment
Chimerix Inc Series F
TyRx Inc N/A
CardioDx Inc Series D Initial investment
TyRx Inc N/A
CoLucid Pharmaceuticals Biopharmaceutical company developing therapeutics to treat neurological dysfunctions. Series B
LipoScience Inc Diagnostic company developing clinical applications of nuclear magnetic resonance (NMR) spectroscopy. Series F
CoLucid Pharmaceuticals Biopharmaceutical company developing therapeutics to treat neurological dysfunctions. Series A
LipoScience Inc Diagnostic company developing clinical applications of nuclear magnetic resonance (NMR) spectroscopy. Series E
Spherics Inc Pharmaceutical company focused on applying its oral drug delivery platform to develop products with improved therapeutic profiles. N/A
Syndax Pharmaceuticals Inc A clinical development company focused on novel oral therapies for cancer. N/A
Syntonix Pharmaceuticals Inc A needle-free drug delivery company utilizing the FcRn receptor to transport macromolecules across epithelial barriers in the central airway and into N/A
TargeGen Inc N/A
Signase N/A
TESARO Inc N/A
Sensys Medical N/A
Anthera Pharmaceuticals Inc N/A
UltraGenyx Pharmaceutical N/A
Variagenics Pharmacogenomics company with proprietary gene variance detection technology anticipated to streamline drug development. N/A
Nuvelo Inc Optimize therapeutic outcomes for patients and their prescribing physicians. N/A
Lumena Pharmaceuticals Inc N/A

Past employees

Selected Products / Customers

Financials